4.7 Review

Bidirectional Role of beta 2-Adrenergic Receptor in Autoimmune Diseases

期刊

FRONTIERS IN PHARMACOLOGY
卷 9, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2018.01313

关键词

autoimmune diseases; beta 2-adrenergic receptor; single nucleotide polymorphisms; immune response; soft regulation

资金

  1. National Natural Science Foundation of China [81330081, 81202541]
  2. Anhui Provincial Natural Science Foundation [1808085J28, 1408085MH173]
  3. Key Projects of Natural Science Research of Anhui Colleges and Universities [KJ2017A176]
  4. Anhui University Excellent Youth Talent Support Program [gxyqZD2017025]
  5. Innovation and Entrepreneurship Support Program for Returnees of Anhui Province
  6. Young Outstanding Doctor Research Program, Anhui Provincial Hospital
  7. Key Research and Development Plan of Anhui Province [1804h08020291]

向作者/读者索取更多资源

Disorder of the sympathetic nervous system (SNS) is closely related to the pathogenesis of various autoimmune diseases (ADs). Catecholamine triggered beta2-adrenergic receptor (beta 2-AR) signaling is important in creating a bidirectional response in the progression of ADs due to factors including diverse expression patterns, single nucleotide polymorphisms (SNPs), biased signals, and desensitization of beta 2-AR, as well as different subtypes of G alpha binding to beta 2-AR. In this review, we summarize the actions of beta 2-AR signaling in regulating the functions of immunocytes and in the pathogenesis of ADs, and the application of beta 2-AR agonists or antagonists in treating major types of ADs is also discussed. We suggest that restoring the immune balance via a soft regulation of the expression or activation of beta 2-AR is one of the promising therapeutic strategies for systematic ADs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据